Breaking News, Financial News

Financial Report: Roche

Revenues up 4% in first half

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche   1H Revenues: CHF 23.3 billion (+4%)   1H Earnings: CHF 6.0 billion (+40%)   Comments: Pharmaceuticals Division sales were 18.1 billion Swiss francs (CHF), up 4%. HER2 franchise grew 11% (CER) to 3.3 billion with successful launches of Perjeta and Kadcyla. Avastin sales were up 12% to 3.1 billion. Diagnostics Division sales were 5.1 billion, up 2%. Significant restructuring charges relating to the closure of the Nutley, NJ site were incurred in 2012....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters